IDYA — Ideaya Biosciences Balance Sheet
0.000.00%
- $1.66bn
- $986.89m
- $7.00m
Annual balance sheet for Ideaya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 284 | 247 | 365 | 525 | 676 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.88 | 1.1 | 0.211 | 0.018 | 0.003 |
Prepaid Expenses | |||||
Total Current Assets | 289 | 251 | 370 | 533 | 690 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.48 | 8.66 | 8.99 | 8.41 | 27.7 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 298 | 381 | 388 | 649 | 1,124 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 38.6 | 45.2 | 31.7 | 27.1 | 46.1 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 100 | 79.8 | 38.5 | 28.2 | 64.9 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 198 | 302 | 349 | 621 | 1,059 |
Total Liabilities & Shareholders' Equity | 298 | 381 | 388 | 649 | 1,124 |
Total Common Shares Outstanding |